Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Notes Payables: 2013-2021

Historic Notes Payables for Capricor Therapeutics (CAPR) over the last 2 years, with Mar 2021 value amounting to $282,691.

  • Capricor Therapeutics' Notes Payables was N/A to $282,691 in Q1 2021 from the same period last year, while for Mar 2021 it was $282,691, marking a year-over-year change of. This contributed to the annual value of $246,689 for FY2020, which is N/A change from last year.
  • Latest data reveals that Capricor Therapeutics reported Notes Payables of $282,691 as of Q1 2021, which was up 14.59% from $246,689 recorded in Q4 2020.
  • Capricor Therapeutics' Notes Payables' 5-year high stood at $282,691 during Q1 2021, with a 5-year trough of $139,927 in Q2 2020.
  • For the 2-year period, Capricor Therapeutics' Notes Payables averaged around $215,637, with its median value being $219,965 (2020).